Company Overview and News

 
Targeting Pods Market worth $4.49 Bn by 2022

2018-02-01 asdnews
The report, now available on ASDReports, "Targeting Pods Market by Type (FLIR & Laser Designator Pods, Laser Spot Tracker), Component (FLIR Sensor, CCD Camera, MMS, ECU, HD TV, Video Datalink), Platform (Combat Aircraft, Helicopters, UAV), Fit (OEM Fit & Upgradation), and Region - Global Forecast to 2022", The targeting pods market is projected to grow from an estimated USD 3.26 Billion in 2017 to USD 4.
Upvote Downvote

 
Thales’s 12-Month Hunt of Gemalto Ends With a Deal - Bloomberg

2017-12-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Tax Reform Propels Global Stocks Higher - WSJ

2017-12-18 wsj
The prospect of U.S. lawmakers passing the most sweeping rewrite of U.S. business and income taxes since the Reagan era continued to propel global stocks higher Monday, fueling gains across U.S. futures, European shares and most Asian markets.
Upvote Downvote

 
Thales Outflanks Atos With Surprise $5.6 Billion Gemalto Bid - Bloomberg

2017-12-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
French aerospace firm Thales buys European SIM maker Gemalto

2017-12-17 livemint
Paris: French aerospace and defence group Thales said on Sunday it has bought European SIM manufacturer Gemalto in a bid to become a global leader in digital security. The aerospace giant paid €51 ($60) a share for Gemalto, a premium of 57% over the closing price on 8 December, Thales said in a statement. The price was also higher than a €46 a share bid offer from French tech firm Atos which Gemalto rejected on Wednesday.
Upvote Downvote

 
Thales to Buy Chip Maker Gemalto for $5.64 Billion - WSJ

2017-12-17 wsj
PARIS—France’s Thales SA has agreed to buy chip maker Gemalto NV for €4.8 billion ($5.64 billion) in a deal that aims to create “a world leader in digital security,” the companies said in a joint statement Sunday.
Upvote Downvote

 
Thales Agrees to Buy Gemalto for $5.42 Billion in All-Cash Offer - Bloomberg

2017-12-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
SMRT train collision due to 'inadvertent' removal of software protection feature - Channel NewsAsia

2017-11-15 channelnewsasia
SINGAPORE: The “inadvertent” disabling of a software protection feature has been identified by the authorities as the reason for an SMRT train hitting another, stalled train at Joo Koon station on Wednesday morning (Nov 15).
Upvote Downvote

 
France and Germany Got Their Railbus. Will the EU Let Them Build It? - Bloomberg

2017-11-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Plante Ousts Coderre to Become Montreal’s First Female Mayor - Bloomberg

2017-11-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Thales creates new artificial intelligence hub in Montreal

2017-10-11 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Paris 2024 Olympics Triggers Race for Contracts Worth Billions - Bloomberg

2017-09-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Air Traffic Control Market by Airspace, Application, Sector, Investment Type, System, and Region - Global Forecast to 2022

2017-08-14 prnewswire
NEW YORK, Aug. 14, 2017 /PRNewswire/ -- "Modernization of air traffic management infrastructure is one of the most significant factors driving the growth of the air traffic control market" The air traffic control market is projected to reach USD 56.07 billion by 2022, at a CAGR of 12.75% from 2017 to 2022. Air Traffic Control (ATC) is an integral part of an airport's infrastructure. With the increasing focus on operational safety and automation at airports, aviation authorities have been investing in the upgrade of ATC equipment to ensure efficient aircraft movement and streamline flight operations.
Upvote Downvote

 
Future of the Saudi Arabia Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2022

2017-08-10 prnewswire
LONDON, Aug. 10, 2017 /PRNewswire/ -- Future of the Saudi Arabia Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2022 Summary Saudi Arabia is one of the largest defense spenders in the world, behind the US, China, and Russia, with a military budget valued at US$50.9 Billion in 2017. The country is the largest market in the Middle East due to its robust economic and financial position backed by its oil exports.
Upvote Downvote

 
Air Traffic Control Market (ATC) Growing at a CAGR of 12.75% During 2017 to 2022 Says a New Research Report at ReportsnReports

2017-08-08 prnewswire
Air traffic control market is projected to reach $56.07 billion by 2022 from $30.77 billion in 2017 at a CAGR of 12.75% from 2017 to 2022 driven by modernization of Air Traffic Management (ATM) infrastructure, increase in the number of airports in emerging economies, and the need for efficient airspace management.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...